e-Casos clínicos
Dermatitis por telaprevir: manejo con corticoides orales en casos refractarios
Management of Refractory Telaprevir-Induced Dermatitis Using Oral Corticosteroids
Leído
11853
Vecesse ha leído el artículo
2454
Total PDF
9399
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 42 | 12 | 54 |
| 2025 5 | 206 | 28 | 234 |
| 2025 4 | 244 | 25 | 269 |
| 2025 3 | 285 | 17 | 302 |
| 2025 2 | 291 | 27 | 318 |
| 2025 1 | 268 | 20 | 288 |
| 2024 12 | 191 | 25 | 216 |
| 2024 11 | 281 | 38 | 319 |
| 2024 10 | 252 | 40 | 292 |
| 2024 9 | 285 | 21 | 306 |
| 2024 8 | 285 | 43 | 328 |
| 2024 7 | 384 | 27 | 411 |
| 2024 6 | 292 | 35 | 327 |
| 2024 5 | 306 | 35 | 341 |
| 2024 4 | 244 | 19 | 263 |
| 2024 3 | 246 | 28 | 274 |
| 2024 2 | 367 | 23 | 390 |
| 2024 1 | 315 | 26 | 341 |
| 2023 12 | 212 | 25 | 237 |
| 2023 11 | 258 | 19 | 277 |
| 2023 10 | 159 | 17 | 176 |
| 2023 9 | 195 | 24 | 219 |
| 2023 8 | 130 | 16 | 146 |
| 2023 7 | 142 | 30 | 172 |
| 2023 6 | 116 | 17 | 133 |
| 2023 5 | 181 | 21 | 202 |
| 2023 4 | 119 | 35 | 154 |
| 2023 3 | 91 | 18 | 109 |
| 2023 2 | 102 | 25 | 127 |
| 2022 1 | 87 | 36 | 123 |
| 2022 12 | 82 | 29 | 111 |
| 2022 11 | 88 | 37 | 125 |
| 2022 10 | 79 | 35 | 114 |
| 2022 9 | 65 | 47 | 112 |
| 2022 8 | 58 | 54 | 112 |
| 2022 7 | 49 | 52 | 101 |
| 2022 6 | 61 | 36 | 97 |
| 2022 5 | 66 | 37 | 103 |
| 2022 4 | 52 | 34 | 86 |
| 2022 3 | 44 | 69 | 113 |
| 2022 2 | 50 | 36 | 86 |
| 2021 1 | 88 | 38 | 126 |
| 2021 12 | 45 | 38 | 83 |
| 2021 11 | 47 | 51 | 98 |
| 2021 10 | 56 | 61 | 117 |
| 2021 9 | 42 | 55 | 97 |
| 2021 8 | 58 | 29 | 87 |
| 2021 7 | 32 | 35 | 67 |
| 2021 6 | 42 | 41 | 83 |
| 2021 5 | 36 | 25 | 61 |
| 2021 4 | 63 | 72 | 135 |
| 2021 3 | 67 | 21 | 88 |
| 2021 2 | 91 | 29 | 120 |
| 2020 1 | 44 | 31 | 75 |
| 2020 12 | 38 | 24 | 62 |
| 2020 11 | 34 | 35 | 69 |
| 2020 10 | 32 | 24 | 56 |
| 2020 9 | 47 | 20 | 67 |
| 2020 8 | 28 | 32 | 60 |
| 2020 7 | 35 | 28 | 63 |
| 2020 6 | 47 | 18 | 65 |
| 2020 5 | 39 | 20 | 59 |
| 2020 4 | 39 | 29 | 68 |
| 2020 3 | 33 | 29 | 62 |
| 2020 2 | 7 | 6 | 13 |
| 2020 1 | 4 | 6 | 10 |
| 2019 12 | 8 | 2 | 10 |
| 2019 11 | 4 | 2 | 6 |
| 2019 10 | 0 | 8 | 8 |
| 2019 9 | 4 | 2 | 6 |
| 2019 8 | 4 | 5 | 9 |
| 2019 7 | 4 | 6 | 10 |
| 2019 6 | 4 | 16 | 20 |
| 2019 5 | 7 | 23 | 30 |
| 2019 4 | 2 | 5 | 7 |
| 2019 3 | 5 | 7 | 12 |
| 2019 2 | 0 | 2 | 2 |
| 2019 1 | 2 | 0 | 2 |
| 2018 12 | 4 | 3 | 7 |
| 2018 11 | 2 | 0 | 2 |
| 2018 10 | 3 | 2 | 5 |
| 2018 9 | 3 | 1 | 4 |
| 2018 6 | 0 | 1 | 1 |
| 2018 5 | 1 | 0 | 1 |
| 2018 3 | 1 | 3 | 4 |
| 2018 2 | 32 | 5 | 37 |
| 2018 1 | 25 | 6 | 31 |
| 2017 12 | 45 | 10 | 55 |
| 2017 11 | 26 | 10 | 36 |
| 2017 10 | 31 | 8 | 39 |
| 2017 9 | 29 | 10 | 39 |
| 2017 8 | 30 | 27 | 57 |
| 2017 7 | 23 | 2 | 25 |
| 2017 6 | 44 | 26 | 70 |
| 2017 5 | 36 | 18 | 54 |
| 2017 4 | 30 | 10 | 40 |
| 2017 3 | 35 | 16 | 51 |
| 2017 2 | 43 | 7 | 50 |
| 2016 1 | 34 | 10 | 44 |
| 2016 12 | 45 | 12 | 57 |
| 2016 11 | 51 | 15 | 66 |
| 2016 10 | 11 | 4 | 15 |
| 2016 9 | 1 | 10 | 11 |
| 2016 8 | 0 | 1 | 1 |
| 2016 7 | 3 | 4 | 7 |
| 2016 6 | 12 | 1 | 13 |
| 2016 5 | 16 | 1 | 17 |
| 2016 4 | 8 | 2 | 10 |
| 2016 3 | 13 | 1 | 14 |
| 2016 2 | 10 | 7 | 17 |
| 2015 1 | 19 | 3 | 22 |
| 2015 12 | 9 | 1 | 10 |
| 2015 11 | 9 | 7 | 16 |
| 2015 10 | 7 | 2 | 9 |
| 2015 9 | 10 | 3 | 13 |
| 2015 8 | 9 | 2 | 11 |
| 2015 7 | 63 | 6 | 69 |
| 2015 6 | 55 | 6 | 61 |
| 2015 5 | 38 | 10 | 48 |
| 2015 4 | 25 | 5 | 30 |
| 2015 3 | 19 | 3 | 22 |
| 2015 2 | 35 | 18 | 53 |
| 2015 1 | 13 | 5 | 18 |
| 2014 12 | 10 | 9 | 19 |
| 2014 11 | 20 | 28 | 48 |
| 2014 10 | 3 | 0 | 3 |
Mostrar todo
